Harvard Health Letter

Medications we're watching

News briefs Three newly approved medications are garnering national attention. The first is an oral form of a powerful opioid painkiller thatís been available by injection since 1984. Dsuvia is the sublingual (under the tongue) version of sufentanil, and it was approved by the FDA in November 2018. Dsuvia is 1,000 times more potent than morphine. The FDA says it may be helpful for use on the battlefield or in hospitals. Critics worry…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In